Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review

Published:2017-10-30 Issue:1 Volume:28 Page:28-51
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Hamasaki Toshimitsu¹²^ORCID,Evans Scott R.³,Asakura Koko¹²

Affiliation:

1. Department of Data Science, National Cerebral and Cardiovascular Center, Osaka, Japan

2. Department of Innovative Clinical Trials and Data Science, Osaka University Graduate School of Medicine, Osaka, Japan

3. Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Heath, MA, USA

Funder

National Institute of Allergy and Infectious Diseases

Japan Agency for Medical Research and Development

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2017.1378668

Reference94 articles.

1. Advanced multiplicity adjustment methods in clinical trials

2. Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective

3. Sample Size Considerations in Clinical Trials When Comparing Two Interventions Using Multiple Co-Primary Binary Relative Risk Contrasts

4. Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trials for Wolfram Syndrome Neurodegeneration: Novel Design, Endpoints, and Analysis Models;2024-09-11

2. Acupuncture for overactive bladder in adults: Study protocol for a randomized controlled trial;Journal of Traditional Chinese Medical Sciences;2024-09

3. A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence;Journal of Cardiovascular Development and Disease;2024-06-21

4. Time to change the paradigm for primary endpoints in cancer screening trials?;JNCI: Journal of the National Cancer Institute;2024-05-23

5. CDC’s Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network;JAMA Network Open;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3